JBN Biotech ApS
CVR 40685693 · Private limited company (ApS) · Active · Low risk
JBN Biotech ApS is a Private limited company (ApS), founded on , based in Hellerup. The company is registered in the industry anden finansiel formidling i.a.n.. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 6 annual reports have been published. The latest annual report (30 Jun 2025) shows equity of DKK 34.9m and a net result of DKK -223k. CEO: Jens Bredal Nielsen.
Bankruptcy risk for JBN Biotech ApS
0.0 × the average (1.41%) · higher risk than 15% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 40685693
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (7 years)
- Address
- Tuborg Boulevard 9, 3. tv
2900 Hellerup - Municipality
- Gentofte
- Industry
- Anden finansiel formidling i.a.n. (649990)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 40k
- Auditor
- Beierholm
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 6 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 74.1% |
| Current ratio | 2% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 3 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -22k | DKK -20k |
| Net profit | DKK -223k | DKK -263k |
| Equity | DKK 34.9m | DKK 35.2m |
| Total assets | DKK 47.1m | DKK 47.0m |
| Cash | DKK 20k | – |
| Short-term debt | DKK 12.2m | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Beierholm.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jul 2024 – 30 Jun 2025 | 154 | ||
| 1 Jul 2023 – 30 Jun 2024 | 152 | ||
| 1 Jul 2022 – 30 Jun 2023 | 171 | ||
| 1 Jul 2021 – 30 Jun 2022 | 147 | ||
| 1 Jul 2020 – 30 Jun 2021 | 163 | ||
| 30 Jul 2019 – 30 Jun 2020 | 154 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Jens Bredal Nielsen | Current | |
| Owner (100%) | Jens Bredal Nielsen | Current | |
| Founder | Jens Bredal Nielsen | Current |
The CEOs' other companies
Jens Bredal Nielsen – 11 other companies, of which 2 bankrupt
- FLUXOME SCIENCES A/S Bankrupt 28 Nov 2012
- GENECARE ApS Bankrupt 29 Nov 2007
- ACCELERACE MANAGEMENT A/S Active
- BII Catalyst AIFM ApS Active
- FLUXOME HOLDING ApS Opløst
- GENECARE DEVELOPMENT ApS Compulsorily dissolved
- HBO. HEDENSTED ApS Fusioneret
- HEDENSTED BOGTRYKKERI ApS Opløst
- JN BIOTECH ApS Active
- MYCOTEQ A/S Opløst
- N&N BIOTECH ApS Opløst
Address history (0 moves)
| Tuborg Boulevard 9, 3. tv, 2900 Hellerup |
Other companies at the same address
- ATECH INGENIØRFIRMA ApS Active
- JN BIOTECH ApS Active
- SPECIALLÆGESELSKABET NIELS HYLDEBRANDT ApS Opløst
Similar companies in Gentofte
- Helle-Broe Invest ApS Gentofte
- SVEND-HENRIK JENSEN ApS Gentofte
- T.C.M.-039 ApS Hellerup
- L. WIMMER. SLAGELSE A/S Charlottenlund
- STEN OLSEN FOTO ApS Charlottenlund
- O. ALBERTSEN TEKNIK A/S Hellerup
- LUNDBERG A/S Hellerup
- BJATOLA A/S Charlottenlund
- PIA HOLTEN REKRUTTERING ApS Gentofte
- UPSTAIRS. SMART TØJ ApS Charlottenlund
- TORBEN HOLME NIELSEN ApS Hellerup
- CHRISTIANE HOLME NIELSEN ApS Hellerup
Questions and answers about JBN Biotech ApS
Has JBN Biotech ApS gone bankrupt?
No, JBN Biotech ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of JBN Biotech ApS?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of JBN Biotech ApS?
Jens Bredal Nielsen is the CEO of JBN Biotech ApS.
Who is the auditor of JBN Biotech ApS?
JBN Biotech ApS most recently used Beierholm.
When was JBN Biotech ApS founded?
JBN Biotech ApS was founded on 30 July 2019.
What is the equity of JBN Biotech ApS?
Equity was DKK 34.9m according to the annual report for the period ending 30 June 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.